{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:57:47Z","timestamp":1787165867490,"version":"build-2736575974"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,3,29]],"date-time":"2016-03-29T00:00:00Z","timestamp":1459209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1038\/mp.2016.35","type":"journal-article","created":{"date-parts":[[2016,3,29]],"date-time":"2016-03-29T04:08:10Z","timestamp":1459224490000},"page":"287-295","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Genome-wide interaction study of brain beta-amyloid burden and cognitive impairment in Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"22","author":[{"name":"for the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI)","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Roostaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6983-0641","authenticated-orcid":false,"given":"A","family":"Nazeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Felsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P L","family":"De Jager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J A","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B G","family":"Pollock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D A","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A N","family":"Voineskos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,29]]},"reference":[{"key":"BFmp201635_CR1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","volume":"12","author":"CR Jack","year":"2013","unstructured":"Jack CR, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS et al. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol 2013; 12: 207\u2013216.","journal-title":"Lancet Neurol"},{"key":"BFmp201635_CR2","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ . The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002; 297: 353\u2013356.","journal-title":"Science"},{"issue":"6","key":"BFmp201635_CR3","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/nn.4018","volume":"18","author":"Erik S Musiek","year":"2015","unstructured":"Musiek ES, Holtzman DM . Three dimensions of the amyloid hypothesis: time, space and'wingmen'. Nat Neurosci 2015; 800\u2013806.","journal-title":"Nature Neuroscience"},{"key":"BFmp201635_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/NEN.0b013e3181919a48","volume":"68","author":"PT Nelson","year":"2009","unstructured":"Nelson PT, Braak H, Markesbery WR . Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship. J Neuropathol Exp Neurol 2009; 68: 1\u201314.","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFmp201635_CR5","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1093\/brain\/awv029","volume":"138","author":"SJ Vos","year":"2015","unstructured":"Vos SJ, Verhey F, Frolich L, Kornhuber J, Wiltfang J, Maier W et al. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage. Brain 2015; 138: 1327\u20131338.","journal-title":"Brain"},{"key":"BFmp201635_CR6","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1097\/MD.0000000000000150","volume":"93","author":"Y Ma","year":"2014","unstructured":"Ma Y, Zhang S, Li J, Zheng DM, Guo Y, Feng J et al. Predictive accuracy of amyloid imaging for progression from mild cognitive impairment to Alzheimer disease with different lengths of follow-up: a meta-analysis. [Corrected]. Medicine (Baltimore) 2014; 93: e150.","journal-title":"Medicine (Baltimore)"},{"key":"BFmp201635_CR7","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1212\/01.WNL.0000063311.58879.01","volume":"60","author":"P Giannakopoulos","year":"2003","unstructured":"Giannakopoulos P, Herrmann FR, Bussiere T, Bouras C, K\u00f6vari E, Perl DP et al. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer\u2019s disease. Neurology 2003; 60: 1495\u20131500.","journal-title":"Neurology"},{"key":"BFmp201635_CR8","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1001\/archneur.60.5.729","volume":"60","author":"AL Guillozet","year":"2003","unstructured":"Guillozet AL, Weintraub S, Mash DC, Mesulam MM . Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. Arch Neurol 2003; 60: 729\u2013736.","journal-title":"Arch Neurol"},{"key":"BFmp201635_CR9","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1001\/archneur.61.3.378","volume":"61","author":"DA Bennett","year":"2004","unstructured":"Bennett DA, Schneider JA, Wilson RS, Bienias JL, Arnold SE . Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch Neurol 2004; 61: 378\u2013384.","journal-title":"Arch Neurol"},{"key":"BFmp201635_CR10","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1001\/jamaneurol.2014.4829","volume":"72","author":"JB Toledo","year":"2015","unstructured":"Toledo JB, Bjerke M, Da X, Landau SM, Foster NL, Jagust W et al. Nonlinear association between cerebrospinal fluid and Florbetapir F-18 beta-amyloid measures across the spectrum of Alzheimer Disease. JAMA Neurol 2015; 72: 571\u2013581.","journal-title":"JAMA Neurol"},{"key":"BFmp201635_CR11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1001\/jama.2010.2008","volume":"305","author":"CM Clark","year":"2011","unstructured":"Clark CM, Schneider JA, Bedell BJ, Beach TG, Bilker WB, Mintun MA et al. Use of florbetapir-PET for imaging \u03b2-amyloid pathology. JAMA 2011; 305: 275\u2013283.","journal-title":"JAMA"},{"key":"BFmp201635_CR12","doi-asserted-by":"publisher","first-page":"e207","DOI":"10.1016\/j.jalz.2010.03.007","volume":"6","author":"MW Weiner","year":"2010","unstructured":"Weiner MW, Aisen PS, Jack CR, Jagust WJ, Trojanowski JQ, Shaw L et al. The Alzheimer's disease neuroimaging initiative: progress report and future plans. Alzheimers Dement 2010; 6: e207.","journal-title":"Alzheimers Dement"},{"key":"BFmp201635_CR13","doi-asserted-by":"publisher","first-page":"628","DOI":"10.2174\/156720512801322573","volume":"9","author":"DA Bennett","year":"2012","unstructured":"Bennett DA, Schneider JA, Arvanitakis Z, Wilson RS . Overview and findings from the religious orders study. Curr Alzheimer Res 2012; 9: 628\u2013645.","journal-title":"Curr Alzheimer Res"},{"key":"BFmp201635_CR14","doi-asserted-by":"publisher","first-page":"646","DOI":"10.2174\/156720512801322663","volume":"9","author":"DA Bennett","year":"2012","unstructured":"Bennett DA, Schneider JA, Buchman AS, Barnes LL, Boyle PA, Wilson RS . Overview and findings from the rush Memory and Aging Project. Curr Alzheimer Res 2012; 9: 646\u2013663.","journal-title":"Curr Alzheimer Res"},{"key":"BFmp201635_CR15","doi-asserted-by":"publisher","first-page":"70","DOI":"10.2967\/jnumed.112.109009","volume":"54","author":"SM Landau","year":"2013","unstructured":"Landau SM, Breault C, Joshi AD, Pontecorvo M, Mathis CA, Jagust WJ et al. Amyloid-\u03b2 imaging with Pittsburgh compound B and florbetapir: comparing radiotracers and quantification methods. J Nucl Med 2013; 54: 70\u201377.","journal-title":"J Nucl Med"},{"key":"BFmp201635_CR16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1159\/000230709","volume":"28","author":"JF Benge","year":"2009","unstructured":"Benge JF, Balsis S, Geraci L, Massman PJ, Doody RS . How well do the ADAS-cog and its subscales measure cognitive dysfunction in Alzheimer\u2019s disease? Dement Geriatr Cogn Disord 2009; 28: 63\u201369.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"BFmp201635_CR17","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/gps.1010","volume":"18","author":"A Estevez-Gonzalez","year":"2003","unstructured":"Estevez-Gonzalez A, Kulisevsky J, Boltes A, Otermin P, Garcia-Sanchez C . Rey verbal learning test is a useful tool for differential diagnosis in the preclinical phase of Alzheimer's disease: comparison with mild cognitive impairment and normal aging. Int J Geriatr Psychiatry 2003; 18: 1021\u20131028.","journal-title":"Int J Geriatr Psychiatry"},{"key":"BFmp201635_CR18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/ana.21610","volume":"65","author":"LM Shaw","year":"2009","unstructured":"Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, Petersen RC et al. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann Neurol 2009; 65: 403\u2013413.","journal-title":"Ann Neurol"},{"key":"BFmp201635_CR19","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1016\/j.neurobiolaging.2015.04.006","volume":"36","author":"L Yu","year":"2015","unstructured":"Yu L, Boyle PA, Leurgans S, Schneider JA, Kryscio RJ, Wilson RS et al. Effect of common neuropathologies on progression of late life cognitive impairment. Neurobiol Aging 2015; 36: 2225\u20132231.","journal-title":"Neurobiol Aging"},{"key":"BFmp201635_CR20","doi-asserted-by":"crossref","unstructured":"Hohman TJ, Chibnik L, Bush WS, Jefferson AL, De Jaeger PL, Thornton-Wells TA et al. GSK3\u03b2 Interactions with Amyloid Genes: An Autopsy Verification and Extension. Neurotox Res 2015; 1\u20137.","DOI":"10.1007\/s12640-015-9541-0"},{"key":"BFmp201635_CR21","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/ana.23654","volume":"72","author":"DA Bennett","year":"2012","unstructured":"Bennett DA, Wilson RS, Boyle PA, Buchman AS, Schneider JA . Relation of neuropathology to cognition in persons without cognitive impairment. Ann Neurol 2012; 72: 599\u2013609.","journal-title":"Ann Neurol"},{"key":"BFmp201635_CR22","doi-asserted-by":"publisher","first-page":"1017.e1","DOI":"10.1016\/j.neurobiolaging.2011.09.033","volume":"33","author":"PL De Jager","year":"2012","unstructured":"De Jager PL, Shulman JM, Chibnik LB, Keenan BT, Raj T, Wilson RS et al. A genome-wide scan for common variants affecting the rate of age-related cognitive decline. Neurobiol Aging 2012; 33: 1017.e1\u20131017.e15.","journal-title":"Neurobiol Aging"},{"key":"BFmp201635_CR23","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/mp.2012.67","volume":"18","author":"ML Hamshere","year":"2013","unstructured":"Hamshere ML, Walters JT, Smith R, Richards AL, Green E, Grozeva D et al. Genome-wide significant associations in schizophrenia to ITIH3\/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC. Mol Psychiatry 2013; 18: 708\u2013712.","journal-title":"Mol Psychiatry"},{"key":"BFmp201635_CR24","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1038\/ncomms3739","volume":"4","author":"T Lencz","year":"2013","unstructured":"Lencz T, Guha S, Liu C, Rosenfeld J, Mukherjee S, DeRosse P et al. Genome-wide association study implicates NDST3 in schizophrenia and bipolar disorder. Nat Commun 2013; 4: 2739.","journal-title":"Nat Commun"},{"key":"BFmp201635_CR25","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1038\/ng.2445","volume":"44","author":"DR Nyholt","year":"2012","unstructured":"Nyholt DR, Low SK, Anderson CA, Painter JN, Uno S, Morris AP et al. Genome-wide association meta-analysis identifies new endometriosis risk loci. Nat Genet 2012; 44: 1355\u20131359.","journal-title":"Nat Genet"},{"key":"BFmp201635_CR26","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1126\/science.1235488","volume":"340","author":"CA Rietveld","year":"2013","unstructured":"Rietveld CA, Medland SE, Derringer J, Yang J, Esko T, Martin NW et al. GWAS of 126,559 individuals identifies genetic variants associated with educational attainment. Science 2013; 340: 1467\u20131471.","journal-title":"Science"},{"key":"BFmp201635_CR27","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1038\/mp.2015.6","volume":"20","author":"RS Desikan","year":"2015","unstructured":"Desikan RS, Schork AJ, Wang Y, Witoelar A, Sharma M, McEvoy LK et al. Genetic overlap between Alzheimer's disease and Parkinson's disease at the MAPT locus. Mol Psychiatry 2015; 20: 1588\u20131595.","journal-title":"Mol Psychiatry"},{"key":"BFmp201635_CR28","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1016\/j.neuroimage.2012.02.084","volume":"61","author":"M Reuter","year":"2012","unstructured":"Reuter M, Schmansky NJ, Rosas HD, Fischl B . Within-subject template estimation for unbiased longitudinal image analysis. Neuroimage 2012; 61: 1402\u20131418.","journal-title":"Neuroimage"},{"key":"BFmp201635_CR29","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1001\/jama.2012.3556","volume":"307","author":"BD James","year":"2012","unstructured":"James BD, Bennett DA, Boyle PA, Leurgans S, Schneider JA . Dementia from Alzheimer disease and mixed pathologies in the oldest old. JAMA 2012; 307: 1798\u20131800.","journal-title":"JAMA"},{"key":"BFmp201635_CR30","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1001\/archneur.65.9.1211","volume":"65","author":"V Haroutunian","year":"2008","unstructured":"Haroutunian V, Schnaider-Beeri M, Schmeidler J, Wysocki M, Purohit DP, Perl DP et al. Role of the neuropathology of Alzheimer disease in dementia in the oldest-old. Arch Neurol 2008; 65: 1211\u20131217.","journal-title":"Arch Neurol"},{"key":"BFmp201635_CR31","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1212\/01.WNL.0000069923.64550.9F","volume":"60","author":"DA Bennett","year":"2003","unstructured":"Bennett DA, Wilson RS, Schneider JA, Evans DA, Mendes de Leon CF, Arnold SE et al. Education modifies the relation of AD pathology to level of cognitive function in older persons. Neurology 2003; 60: 1909\u20131915.","journal-title":"Neurology"},{"key":"BFmp201635_CR32","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1212\/WNL.0b013e318295d7a1","volume":"80","author":"SE Monsell","year":"2013","unstructured":"Monsell SE, Mock C, Roe CM, Ghoshal N, Morris JC, Cairns NJ et al. Comparison of symptomatic and asymptomatic persons with Alzheimer disease neuropathology. Neurology 2013; 80: 2121\u20132129.","journal-title":"Neurology"},{"key":"BFmp201635_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"BT Hyman","year":"2012","unstructured":"Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC et al. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement 2012; 8: 1\u201313.","journal-title":"Alzheimers Dement"},{"key":"BFmp201635_CR34","first-page":"1293","volume":"137","author":"E Masliah","year":"1990","unstructured":"Masliah E, Terry RD, Mallory M, Alford M, Hansen LA . Diffuse plaques do not accentuate synapse loss in Alzheimer's disease. Am J Pathol 1990; 137: 1293\u20131297.","journal-title":"Am J Pathol"},{"key":"BFmp201635_CR35","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1111\/j.1582-4934.2008.00411.x","volume":"12","author":"DR Thal","year":"2008","unstructured":"Thal DR, Griffin WS, Braak H . Parenchymal and vascular Abeta-deposition and its effects on the degeneration of neurons and cognition in Alzheimer's disease. J Cell Mol Med 2008; 12: 1848\u20131862.","journal-title":"J Cell Mol Med"},{"key":"BFmp201635_CR36","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1126\/science.1197623","volume":"330","author":"KG Mawuenyega","year":"2010","unstructured":"Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC et al. Decreased clearance of CNS beta-amyloid in Alzheimer's disease. Science 2010; 330: 1774.","journal-title":"Science"},{"key":"BFmp201635_CR37","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"J Lonsdale","year":"2013","unstructured":"Lonsdale J, Thomas J, Salvatore M, Phillips R, Lo E, Shad S et al. The genotype-tissue expression (GTEx) project. Nat Genet 2013; 45: 580\u2013585.","journal-title":"Nat Genet"},{"key":"BFmp201635_CR38","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1038\/nn.3801","volume":"17","author":"A Ramasamy","year":"2014","unstructured":"Ramasamy A, Trabzuni D, Guelfi S, Varghese V, Smith C, Walker R et al. Genetic variability in the regulation of gene expression in ten regions of the human brain. Nat Neurosci 2014; 17: 1418\u20131428.","journal-title":"Nat Neurosci"},{"key":"BFmp201635_CR39","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.neurobiolaging.2013.10.076","volume":"35","author":"BL Adler","year":"2014","unstructured":"Adler BL, Yarchoan M, Hwang HM, Louneva N, Blair JA, Palm R et al. Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition. Neurobiol Aging 2014; 35: 793\u2013801.","journal-title":"Neurobiol Aging"},{"key":"BFmp201635_CR40","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3389\/fnagi.2014.00186","volume":"6","author":"WQ Qiu","year":"2014","unstructured":"Qiu WQ, Zhu H . Amylin and its analogs: a friend or foe for the treatment of Alzheimer's disease? Front Aging Neurosci 2014; 6: 186.","journal-title":"Front Aging Neurosci"},{"key":"BFmp201635_CR41","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3233\/JAD-140210","volume":"42","author":"WQ Qiu","year":"2014","unstructured":"Qiu WQ, Au R, Zhu H, Wallack M, Liebson E, Li H et al. Positive association between plasma amylin and cognition in a homebound elderly population. J Alzheimers Dis 2014; 42: 555\u2013563.","journal-title":"J Alzheimers Dis"},{"key":"BFmp201635_CR42","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3389\/fnins.2015.00216","volume":"9","author":"TA Lutz","year":"2015","unstructured":"Lutz TA, Meyer U . Amylin at the interface between metabolic and neurodegenerative disorders. Front Neurosci 2015; 9: 216.","journal-title":"Front Neurosci"},{"key":"BFmp201635_CR43","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/ana.23956","volume":"74","author":"K Jackson","year":"2013","unstructured":"Jackson K, Barisone GA, Diaz E, Lw Jin, DeCarli C, Despa F . Amylin deposition in the brain: a second amyloid in Alzheimer disease? Ann Neurol 2013; 74: 517\u2013526.","journal-title":"Ann Neurol"},{"key":"BFmp201635_CR44","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJM200011233432106","volume":"343","author":"FH Epstein","year":"2000","unstructured":"Epstein FH, H\u00f6ppener JWM, Ahr\u00e9n B, Lips CJM . Islet amyloid and type 2 diabetes mellitus. N Engl J Med 2000; 343: 411\u2013419.","journal-title":"N Engl J Med"},{"key":"BFmp201635_CR45","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1111\/j.1471-4159.1993.tb07480.x","volume":"61","author":"PC May","year":"1993","unstructured":"May PC, Boggs LN, Fuson KS . Neurotoxicity of human amylin in rat primary hippocampal cultures: similarity to Alzheimer's disease amyloid-\u03b2 neurotoxicity. J Neurochem 1993; 61: 2330\u20132333.","journal-title":"J Neurochem"},{"key":"BFmp201635_CR46","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1750-1326-9-30","volume":"9","author":"S Srodulski","year":"2014","unstructured":"Srodulski S, Sharma S, Bachstetter AB, Brelsfoard JM, Pascual C, Xie XS et al. Neuroinflammation and neurologic deficits in diabetes linked to brain accumulation of amylin. Mol Neurodegener 2014; 9: 30.","journal-title":"Mol Neurodegener"},{"key":"BFmp201635_CR47","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3389\/fnagi.2013.00042","volume":"5","author":"W Fu","year":"2013","unstructured":"Fu W, Patel A, Jhamandas JH . Amylin receptor: a common pathophysiological target in Alzheimer's disease and diabetes mellitus. Front Aging Neurosci 2013; 5: 42.","journal-title":"Front Aging Neurosci"},{"key":"BFmp201635_CR48","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ajpath.2010.11.022","volume":"178","author":"JH Jhamandas","year":"2011","unstructured":"Jhamandas JH, Li Z, Westaway D, Yang J, Jassar S, MacTavish D . Actions of \u03b2-amyloid protein on human neurons are expressed through the amylin receptor. Am J Pathol 2011; 178: 140\u2013149.","journal-title":"Am J Pathol"},{"key":"BFmp201635_CR49","doi-asserted-by":"publisher","first-page":"5579","DOI":"10.1523\/JNEUROSCI.1051-04.2004","volume":"24","author":"JH Jhamandas","year":"2004","unstructured":"Jhamandas JH, MacTavish D . Antagonist of the amylin receptor blocks \u03b2-amyloid toxicity in rat cholinergic basal forebrain neurons. J Neurosci 2004; 24: 5579\u20135584.","journal-title":"J Neurosci"},{"key":"BFmp201635_CR50","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/nature05143","volume":"443","author":"Y Shen","year":"2006","unstructured":"Shen Y, Joachimiak A, Rosner MR, Tang W-J . Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism. Nature 2006; 443: 870\u2013874.","journal-title":"Nature"},{"key":"BFmp201635_CR51","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/mp.2014.17","volume":"20","author":"H Zhu","year":"2015","unstructured":"Zhu H, Wang X, Wallack M, Li H, Carreras I, Dedeoglu A et al. Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimer\u2019s disease. Mol Psychiatry 2015; 20: 252\u2013262.","journal-title":"Mol Psychiatry"},{"key":"BFmp201635_CR52","doi-asserted-by":"publisher","first-page":"6155","DOI":"10.1038\/srep06155","volume":"4","author":"M Yoshimura","year":"2014","unstructured":"Yoshimura M, Ono M, Watanabe H, Kimura H, Saji H . Feasibility of amylin imaging in pancreatic islets with beta-amyloid imaging probes. Sci Rep 2014; 4: 6155.","journal-title":"Sci Rep"},{"key":"BFmp201635_CR53","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1093\/bioinformatics\/btq419","volume":"26","author":"RJ Pruim","year":"2010","unstructured":"Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, Gliedt TP et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 2010; 26: 2336\u20132337.","journal-title":"Bioinformatics"},{"key":"BFmp201635_CR54","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1101\/gr.135350.111","volume":"22","author":"J Harrow","year":"2012","unstructured":"Harrow J, Frankish A, Gonzalez JM, Tapanari E, Diekhans M, Kokocinski F et al. GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res 2012; 22: 1760\u20131774.","journal-title":"Genome Res"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/mp201635.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/mp201635","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/mp201635.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T14:16:35Z","timestamp":1684419395000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/mp201635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,29]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["BFmp201635"],"URL":"https:\/\/doi.org\/10.1038\/mp.2016.35","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,29]]},"assertion":[{"value":"16 September 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}